Description: Sotuletinib (BLZ945) is an orally active, effective and specific CSF-1R inhibitor (IC50: 1 nM), >1000-fold selective against its closest receptor tyrosine kinase homologs. Target: c-Fms, CSF-1R. Smiles: CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1. References: Pyonteck SM, et al. Nat Med. 2013,...

BLZ-945 is a selective inhibitor of the colony stimulating factor 1 receptor (CSF1R) with an IC50 value of 1 nM. It is more than 1,000-fold selective against its closest receptor tyrosine kinase homologs. It has been shown to inhibit CSF1-dependent proliferation with an EC50 value of 67 nM in bone marrow-derived...

Soluble in DMSO. BLZ945 is an orally active, potent and selective CSF-1R inhibitor, which inhibits CSF-1R activity with an IC(50) of 1nM and is more than 1000-fold selective against its closest receptor tyrosine kinase homologs c-KIT and Platelet-derived Growth Factor Receptor beta (PDGFRbeta ) as well as more than...

Pale yellow solid. Soluble in DMSO. Slightly soluble in ethanol. Insoluble in water. Anticancer compound, Orally active, potent and selective colony stimulating factor 1 receptor (CSF-1R, c-Fms) inhibitor, More than 1000-fold selective against its closest receptor tyrosine kinase homologs c-KIT and platelet-derived...

CSF-1R Inhibitor.